相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thymalfasin in the treatment of hepatitis B and C
A. Ciancio et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly
Xuejun Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Interferon-α-Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection
Kerstin A. Stegmann et al.
GASTROENTEROLOGY (2010)
Antiviral Activity and Safety of LB80380 in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients with Lamivudine-Resistant Disease
Man-Fung Yuen et al.
HEPATOLOGY (2010)
The Acyclic 2,4-Diaminopyrimidine Nucleoside Phosphonate Acts as a Purine Mimetic in HIV-1 Reverse Transcriptase DNA Polymerization
Brian D. Herman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The replication cycle of hepatitis B virus
Stephan Urban et al.
JOURNAL OF HEPATOLOGY (2010)
Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites
Dianxing Sun et al.
JOURNAL OF HEPATOLOGY (2010)
Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
Markus Mordstein et al.
JOURNAL OF VIROLOGY (2010)
Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities
Nicole E. Pagliaccetti et al.
VIROLOGY (2010)
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
Jean-Pierre Vartanian et al.
PLOS PATHOGENS (2010)
Pharmacokinetics of LB80331 and LB80317 following Oral Administration of LB80380, a New Antiviral Agent for Chronic Hepatitis B (CHB), in Healthy Adult Subjects, CHB Patients, and Mice
Man-Fung Yuen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Type III IFNs: New layers of complexity in innate antiviral immunity
Nina Ank et al.
BIOFACTORS (2009)
The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2α Via Protein Kinase Activated by Double-Stranded RNA Activation
Menashe Elazar et al.
GASTROENTEROLOGY (2009)
Novel Insights Into the Association Between HLA-DP Variants and Persistent Hepatitis B Virus Infection: A Genome-wide Association Study
George K. Lau et al.
GASTROENTEROLOGY (2009)
Clevudine myopathy in patients with chronic hepatitis B
Byung Kook Kim et al.
JOURNAL OF HEPATOLOGY (2009)
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
Elisabetta Loggi et al.
JOURNAL OF HEPATOLOGY (2009)
Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B
Russell D. Fleischer et al.
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Interferon-alfa, interferon-lambda and hepatitis C
Thomas R. O'Brien
NATURE GENETICS (2009)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Yoichiro Kamatani et al.
NATURE GENETICS (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-I for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides
Emmet B. Keeffe et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Antonio Bertoletti et al.
Expert Review of Gastroenterology & Hepatology (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters
Ya Ping Tseng et al.
ANTIVIRAL RESEARCH (2008)
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
Brent E. Korba et al.
ANTIVIRAL RESEARCH (2008)
Viral Hepatitis B: Established and emerging therapies
Clara Balsano et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C
Jean-Francois Rossignol et al.
FUTURE MICROBIOLOGY (2008)
Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly
Guo-Yi Wu et al.
JOURNAL OF CHEMOTHERAPY (2008)
Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H
Josef Koeck et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
Richard E. Randall et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
Joseph J. Y. Sung et al.
JOURNAL OF HEPATOLOGY (2008)
Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture
Kimberley A. Zimmerman et al.
JOURNAL OF VIROLOGY (2008)
Small-Molecule Effectors of Hepatitis B Virus Capsid Assembly Give Insight into Virus Life Cycle
Christina Bourne et al.
JOURNAL OF VIROLOGY (2008)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients
Dao-Zhen Xu et al.
PLOS ONE (2008)
Hepatitis B viruses: Reverse transcription a different way
Michael Nassal
VIRUS RESEARCH (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy:: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
Pierre Vandepapeliere et al.
VACCINE (2007)
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
J. J. Feld et al.
ANTIVIRAL RESEARCH (2007)
Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells
Seung-Ho Hong et al.
VIRUS RESEARCH (2007)
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants
M. N. Brunelle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue
Chunxiao Ying et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients
Xin Yao et al.
VACCINE (2007)
Nitazoxanide - A review of its use in the treatment of gastrointestinal infections
Vanessa R. Anderson et al.
DRUGS (2007)
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stephen J. Stray et al.
JOURNAL OF MOLECULAR RECOGNITION (2006)
Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus
Dianxing Sun et al.
JOURNAL OF HEPATOLOGY (2006)
Consequences of receptor editing at the λ locus:: Multireactivity and light chain secretion
Colleen M. Doyle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
IFN-λ:: Novel antiviral cytokines
Nina Ank et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones
T Pollicino et al.
GASTROENTEROLOGY (2006)
Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: A randomized controlled study
HL Weng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
APOBEC-mediated interference with hepadnavirus production
C Rösler et al.
HEPATOLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
SJ Stray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Liver-targeted drug delivery using HepDirect1 prodrugs
MD Erion et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Inhibition of hepatitis B virus replication by APOBEC3G
P Turelli et al.
SCIENCE (2004)
Signal transduction pathways that inhibit hepatitis B virus replication
MD Robek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
HIV-1 gp41 as a target for viral entry inhibition
MJ Root et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines:: A new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity
J Balzarini et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies:: induction of a vaccine-specific CD4+T-cell proliferative response in chronic hepatitis B carriers
MC Jung et al.
VACCINE (2002)
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B
S Pol et al.
JOURNAL OF HEPATOLOGY (2001)
Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase:: Therapeutic implications
A Mehta et al.
HEPATOLOGY (2001)
Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
P Bailon et al.
BIOCONJUGATE CHEMISTRY (2001)
Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen
F Rahman et al.
HEPATOLOGY (2000)
分享论文
